Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8 + - T cell-mediated anti-tumor immunity
Theranostics · 2024
DOI: 10.7150/thno.97276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Xin Xin und 9 weiteren Autor:innen. Beteiligte Einrichtung: The College of Life Science and Bioengineering, Beijing Jiaotong University, Beijing, China. Hauptthemen laut MEDLINE: Carcinogenesis, Carcinoma, Hepatocellular, CD8-Positive T-Lymphocytes, Chemokine CXCL10. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The College of Life Science and Bioengineering, Beijing Jiaotong University, Beijing, China.
- Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.
- School of Life Science and Technology, Jinan University, Guangzhou, Guangdong province, China.
- Faculty of Environmental and Life Sciences, Beijing University of Technology, Beijing, China.
- Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan province, China.
Zitieren
APA
Xin, X., Li, Z., Yan, X., Liu, T., Li, Z., Chen, Z., Yan, X., Zeng, F., Hou, L., & Zhang, J. (2024). Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8 + - T cell-mediated anti-tumor immunity. Theranostics. https://doi.org/10.7150/thno.97276
Vancouver
Xin X, Li Z, Yan X, Liu T, Li Z, Chen Z, et al. Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8 + - T cell-mediated anti-tumor immunity. Theranostics. 2024. doi:10.7150/thno.97276
BibTeX
@article{Xin2024,
author = {Xin, Xin and Li, Zhao and Yan, Xuanxuan and Liu, Ting and Li, Zuyin and Chen, Zhuomiaoyu and Yan, Xinlong and Zeng, Fanxin and Hou, Lingling and Zhang, Jinhua},
title = {Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8 + - T cell-mediated anti-tumor immunity},
journal = {Theranostics},
year = {2024},
doi = {10.7150/thno.97276}
}
EUVIMED